Investing.comCodex · 实盘不做把握 8/10不做原因:消息已过时
北京时间·🕒 发布 20:40:34·⟳ 抓取 20:41:14 +40s·⚡ 决策 08-31 20:43:03 +1m49s·56.8 天前
OneMedNet供AI药物开发数据协议为7月已披露旧闻
事件方向对OneMedNet本身偏正面，但可核验的一手公司新闻显示同一核心合同已在2026年7月28日披露，8月31日转述没有新增可交易事实。
📄 原文Investing.com↗ 原文
OneMedNet secures AI drug development data agreement
Oil jumps 3% as U.S. strikes on Iran revive Hormuz supply disruption concerns MINNEAPOLIS - OneMedNet Corporation (NASD…
不做 OneMedNet Corporation（ONMD.US）
不做OneMedNet Corporation（ONMD.US）：8月31日稿件缺少新增金额、客户或指引，核心1150万美元数据供应协议已在7月28日一手披露，属于旧催化再传播。
不做 Palantir Technologies Inc.（PLTR.US）
不做Palantir Technologies Inc.（PLTR.US）：事件只是OneMedNet客户数据供应合同，未披露Palantir新增合同收入或基本面增量。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
OneMedNet的数据协议若是新合同本可提升其小市值收入预期；但网页核查显示公司官网7月28日已发布超过1150万美元的同类协议，当前Investing.com正文没有新增金额、客户身份、指引或监管进展，属于旧催化再传播，短线不具备新增edge。
消息传播链
- GlobeNewswire列表显示OneMedNet在2026年7月28日08:30 ET发布超过1150万美元监管级真实世界数据供应协议。
- 公司官网同日披露协议总合同价值超过1150万美元并立即交付数据。
- Investing.com转述OneMedNet向AI药物开发公司提供数据协议，但正文未见相对7月28日披露的新增金额或条款。
关键理由
- 公司官网7月28日已披露超过1150万美元数据供应协议，相对其2025年279万美元booking基数名义重大。
- 但8月31日稿件未提供新金额、新客户名称或新履约节点，不能视为新增订单催化。
主要风险
- 旧闻再传播可能造成盘前噪音波动，追高容易买在已披露催化后的二次扩散。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-07-28 · 影响 invalidates
同一核心合同新闻在公司官网和GlobeNewswire已于7月28日披露，削弱8月31日做多新鲜度。
检索:OneMedNet AI drug development data agreement August 31 2026 July 28 2026 原文 ↗
先例如何影响了这次决策
对本次决策的影响:先例未改变结论；核心否决点是本次信号无新增事实。
方向:未进入可交易阶段；旧闻重复已足以否决本次交易，不使用外部先例校准方向。
涨幅量级:未使用先例校准幅度。
形态:不适用。
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- web_search 成功 ? · 0 ms
原文全文
展开原文 · 1,777 字
Oil jumps 3% as U.S. strikes on Iran revive Hormuz supply disruption concerns
MINNEAPOLIS - OneMedNet Corporation (NASDAQ:ONMD) announced today an agreement to provide de-identified clinical real-world data to an AI-driven drug development company, according to a press release statement.
The company’s iRWD platform completed cohort feasibility within minutes, data validation within a week, and contract signing within three weeks of initial contact. The data will support the development and validation of AI models for drug discovery and development.
OneMedNet provides first-party data sourced directly from healthcare providers. The company’s network includes more than 2,300 healthcare partner sites, encompassing over 90 million patient journeys and 270 million studies.
"Healthcare innovators are coming to OneMedNet because they see what it takes to build AI that performs in the real world: private clinical data sourced directly from healthcare providers," said Aaron Green, President and CEO of OneMedNet.
The agreement delivers regulatory decision-grade quality data, including de-identified medical imaging and clinical records. OneMedNet’s multimodal data spans radiology, cardiology, EEG, ECG, and other diagnostic modalities, alongside de-identified electronic health records.
OneMedNet Corporation operates a real-world data platform that delivers de-identified medical imaging and clinical records. The platform is powered by Palantir Foundry and serves life sciences companies, medical device manufacturers, and AI developers. The company’s services support applications including drug development, regulatory submissions, and AI model training.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
MINNEAPOLIS - OneMedNet Corporation (NASDAQ:ONMD) announced today an agreement to provide de-identified clinical real-world data to an AI-driven drug development company, according to a press release statement.
The company’s iRWD platform completed cohort feasibility within minutes, data validation within a week, and contract signing within three weeks of initial contact. The data will support the development and validation of AI models for drug discovery and development.
OneMedNet provides first-party data sourced directly from healthcare providers. The company’s network includes more than 2,300 healthcare partner sites, encompassing over 90 million patient journeys and 270 million studies.
"Healthcare innovators are coming to OneMedNet because they see what it takes to build AI that performs in the real world: private clinical data sourced directly from healthcare providers," said Aaron Green, President and CEO of OneMedNet.
The agreement delivers regulatory decision-grade quality data, including de-identified medical imaging and clinical records. OneMedNet’s multimodal data spans radiology, cardiology, EEG, ECG, and other diagnostic modalities, alongside de-identified electronic health records.
OneMedNet Corporation operates a real-world data platform that delivers de-identified medical imaging and clinical records. The platform is powered by Palantir Foundry and serves life sciences companies, medical device manufacturers, and AI developers. The company’s services support applications including drug development, regulatory submissions, and AI model training.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。